Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin).
IOVA Key Statistics
Stock Snapshot
With a market cap of 6.18B, Iovance Biotherapeutics(IOVA) trades at $13.63. The stock has a price-to-earnings ratio of -18.88.
On 2026-10-17, Iovance Biotherapeutics(IOVA) stock moved within a range of $13.52 to $14.80. With shares now at $13.63, the stock is trading +0.9% above its intraday low and -7.9% below the session's peak.
Trading activity shows a volume of 12.19M, compared to an average daily volume of 13.23M.
Over the past 52 weeks, Iovance Biotherapeutics(IOVA) stock has traded between a high of $15.30 and a low of $1.76.
Over the past 52 weeks, Iovance Biotherapeutics(IOVA) stock has traded between a high of $15.30 and a low of $1.76.
IOVA News
Iovance Biotherapeutics (IOVA) announced an update on their ongoing clinical study. Iovance Biotherapeutics, Inc. has halted a Phase 1 study titled “A Phase 1,...
...
Iovance Biotherapeutics recently raised its full-year 2026 revenue outlook to a range of $410 million to $420 million, citing strong U.S. demand for Amtagvi and...
Analyst ratings
80%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.